The 12 analysts offering 12-month price forecasts for Encompass Health Corp have a median target of 82.50, with a high estimate of 85.00 and a low estimate of 79.00. The median estimate represents a +27.59% increase from the last price of 64.66.
The current consensus among 13 polled investment analysts is to Buy stock in Encompass Health Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.00
Reporting Date Aug 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.